David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 23.09% |
| 2 | Technology | 17.04% |
| 3 | Healthcare | 13.44% |
| 4 | Consumer Discretionary | 13.38% |
| 5 | Financials | 7.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2401
PUT
Ambarella
AMBA
$3.1B
| $1.3M | ﹤0.01% |
30,000
-40,000
| -57% | -$1.58M |
|
|
SYKE
2402
DELISTED
SYKES Enterprises Inc
SYKE
| $1.3M | ﹤0.01% |
45,825
-7,518
| -14% | -$212K |
|
|
AKCA
2403
DELISTED
Akcea Therapeutics Inc
AKCA
| $1.29M | ﹤0.01% |
+45,676
| New | +$1.33M |
|
2404
CALL
Strategic Education
STRA
$1.91B
| $1.29M | ﹤0.01% |
9,800
+3,530
| +56% | +$430K |
|
2405
CALL
DXC Technology
DXC
$1.75B
| $1.29M | ﹤0.01% |
20,000
-55,000
| -73% | -$3.52M |
|
|
2406
PUT
DXC Technology
DXC
$1.75B
| $1.29M | ﹤0.01% |
20,000
| – | – |
|
2407
Grupo Aval
AVAL
$6.36B
| $1.28M | ﹤0.01% |
164,949
-66,919
| -29% | -$481K |
|
2408
SLR Investment Corp
SLRC
$681M
| $1.28M | ﹤0.01% |
61,645
+49,898
| +425% | +$1.04M |
|
2409
Helix Energy Solutions
HLX
$1.45B
| $1.28M | ﹤0.01% |
162,336
+16,800
| +12% | +$120K |
|
|
SMI
2410
DELISTED
Semiconductor Manufacturing Intl
SMI
| $1.28M | ﹤0.01% |
253,751
+83,187
| +49% | +$401K |
|
2411
Crane NXT
CXT
$2.91B
| $1.28M | ﹤0.01% |
43,585
-13,612
| -24% | -$385K |
|
2412
Zions Bancorporation
ZION
$9.87B
| $1.28M | ﹤0.01% |
+28,193
| New | +$1.35M |
|
|
LTXB
2413
DELISTED
LegacyTexas Financial Group Inc
LTXB
| $1.28M | ﹤0.01% |
34,236
+22,912
| +202% | +$895K |
|
2414
Liberty Latin America Class A
LILA
$1.66B
| $1.27M | ﹤0.01% |
+102,889
| New | +$1.2M |
|
|
AQ
2415
DELISTED
Aquantia Corp. Common Stock
AQ
| $1.27M | ﹤0.01% |
+140,347
| New | +$1.2M |
|
2416
CALL
Avis
CAR
$5.07B
| $1.27M | ﹤0.01% |
36,400
+18,200
| +100% | +$545K |
|
|
ADAP
2417
DELISTED
Adaptimmune Therapeutics
ADAP
| $1.27M | ﹤0.01% |
294,573
+80,412
| +38% | +$374K |
|
|
NBL
2418
PUT
DELISTED
Noble Energy, Inc.
NBL
| $1.27M | ﹤0.01% |
51,200
+30,000
| +142% | +$679K |
|
2419
The GEO Group
GEO
$4.26B
| $1.26M | ﹤0.01% |
65,900
-520,498
| -89% | -$11.2M |
|
2420
VEON
VEON
$4.16B
| $1.26M | ﹤0.01% |
+24,187
| New | +$1.51M |
|
2421
CALL
Ollie's Bargain Outlet
OLLI
$4.38B
| $1.26M | ﹤0.01% |
14,800
| – | – |
|
2422
Allegion
ALLE
$13.6B
| $1.26M | ﹤0.01% |
13,900
-9
| -0.1% | -$783 |
|
2423
Aqua Metals
AQMS
$9.95M
| $1.26M | ﹤0.01% |
+2,054
| New | +$1.14M |
|
|
JOYY
2424
CALL
JOYY Inc
JOYY
$3.72B
| $1.26M | ﹤0.01% |
15,000
-69,300
| -82% | -$5.04M |
|
2425
Talos Energy
TALO
$2.77B
| $1.26M | ﹤0.01% |
47,400
-25,340
| -35% | -$550K |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $2.66B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 23% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.